| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Revenue | $1.0B | $2.8B | $1.7B |
| Cost of Revenue | — | — | — |
| Gross Profit | — | — | — |
| R&D Expense | — | — | — |
| SG&A Expense | $1.5B | $1.2B | $0.5B |
| Operating Income | $0.1B | $0.3B | $0.4B |
| Net Income | $-0.0B | $0.0B | $-0.0B |
| EPS (Basic) | $-0.03 | $0.12 | $-0.43 |
| EPS (Diluted) | $-0.08 | $0.02 | $-0.43 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Total Assets | $15.5B | $12.7B | $12.7B |
| Current Assets | $2.3B | $0.9B | $0.5B |
| Cash & Equivalents | $0.8B | $0.5B | $0.2B |
| Total Liabilities | $6.2B | $4.0B | $3.8B |
| Current Liabilities | $1.8B | $0.7B | $0.5B |
| Stockholders' Equity | $3.7B | $4.1B | $4.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Operating Cash Flow | $1.3B | $0.6B | $0.5B |
| Investing Cash Flow | $-0.1B | $-0.1B | $0.0B |
| Capital Expenditures | — | — | — |
| Financing Cash Flow | $-0.6B | $-0.2B | $-0.4B |